Identification of driver genes in hepatocellular carcinoma by exome sequencing.
about
Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advancesMolecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis?The mutational landscape of hepatocellular carcinomaTargeting the mTOR pathway in hepatocellular carcinoma: current state and future trendsEpigenetics in liver diseaseMultidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.Genetic alterations in hepatocellular carcinoma: An updateEpigenetics in liver disease: from biology to therapeuticsDysregulation of ubiquitin ligases in cancerp62 links autophagy and Nrf2 signalingA Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma CellsMutations acquired by hepatocellular carcinoma recurrence give rise to an aggressive phenotype.CRISPR/Cas9-mediated p53 and Pten dual mutation accelerates hepatocarcinogenesis in adult hepatitis B virus transgenic mice.Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumorsIdentification and analysis of driver missense mutations using rotation forest with feature selection.The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients.Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis.MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches.Profiling of exome mutations associated with progression of HBV-related hepatocellular carcinoma.Reciprocal interaction of Wnt and RXR-α pathways in hepatocyte development and hepatocellular carcinoma.p53 requires the stress sensor USF1 to direct appropriate cell fate decision.DNA markers in molecular diagnostics for hepatocellular carcinoma.Liver cancer oncogenomics: opportunities and dilemmas for clinical applications.Significance of genetic variants in DLC1 and their association with hepatocellular carcinomaAccumulation of Deleterious Passenger Mutations Is Associated with the Progression of Hepatocellular CarcinomaHow do persistent infections with hepatitis C virus cause liver cancer?Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancerTargeted DNA and RNA sequencing of fine-needle biopsy FFPE specimens in patients with unresectable hepatocellular carcinoma treated with sorafenib.Gankyrin has an antioxidative role through the feedback regulation of Nrf2 in hepatocellular carcinoma.A genomic case study of mixed fibrolamellar hepatocellular carcinomaSorafenib in advanced hepatocellular carcinoma: current status and future perspectives.Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral HeterogeneityThe MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers.Clinical implication of Keap1 and phosphorylated Nrf2 expression in hepatocellular carcinoma.Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma.From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic CancersClinical outcomes based on multigene profiling in metastatic breast cancer patientsThe importance of a multidisciplinary approach to hepatocellular carcinoma.TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma.Examining the impact of gene variants on histone lysine methylation
P2860
Q26745338-643979C2-C43A-459E-B2D8-F7E01D261E9EQ26766689-0EDB3B7C-2306-41FE-B068-F6F725E82AEFQ26777478-3059DDD0-5BC9-4502-A9A8-C9B97069ACC0Q26830194-FAFF4BC9-8331-4C8A-B4DD-812D37CD87F2Q26849263-317FEC4D-3400-41C1-BA98-9E055B3C5AD9Q26998606-F24C0823-140A-411E-BB86-652E2609B234Q28073241-64E943D2-C633-4479-B380-49F505A6ADABQ28079271-5A0E7A9F-A15D-4F48-9E3F-3B4C5DE8A207Q28086796-D45448EC-21F7-4E13-A404-5A3A4F1FB6B8Q28392820-240B33C5-DE9B-4A0E-AD5D-44314534F1FEQ28553513-C07EE7E3-3B2A-4395-9311-82411548BC4AQ33618512-D806E3AF-A904-405F-858D-7CF32A99FFDBQ33765935-0E8BF10F-5D84-47DD-855B-43635387BA1FQ33820159-E326C3EE-D309-454C-B274-A2C4C9F389D6Q34177518-0066EA0D-A23C-4DA5-80F1-61B1B7142640Q34458870-21D2E839-78F1-4526-9A86-38530B60326EQ34619389-C4279B0E-1C27-4EA8-A558-B8AD2D66EA93Q34675280-4ED94C56-CDAA-4447-AEE8-6D8528CB716BQ34734133-866663E0-48AA-4695-81DA-E918FEFA2284Q35147588-4889353D-D540-4E0C-9E94-9FCF40C8D041Q35169245-7CD9D513-6A9D-495A-AE14-10A681CD1D22Q35781255-C90EBFF2-95A7-4BC2-8B03-DF30F16BDBF5Q35913384-C3813D73-B2C7-41C2-A3AA-F16545189707Q35919725-73546947-F0CF-4707-9059-1786BA92B0DAQ36134242-2A511002-B5B8-4912-8BFB-5BC92B92461EQ36236839-E95532E6-A953-4BDD-B6F1-D8AF439E9E79Q36319724-13804A04-97C4-4357-98FE-03CF7221552AQ36356419-608FCB01-E231-407B-854A-C41AE2F8E658Q36863127-65056855-8263-4B1B-91AA-94453B495E7DQ36935210-38226131-F507-4F74-83F4-51C6660AD8CFQ37031712-D1B11338-AFBE-4597-86EA-2AD1E5D21172Q37290515-D6B0FDCE-C35F-41DE-8960-84C69612BA2CQ37336099-74D9228E-FA99-42A1-B00B-A49B2162C6D0Q37373034-8C80B489-322E-46C9-BA96-B4E2461B99F7Q37408915-687AE213-C894-4A84-B86A-75C120A5529EQ37631655-299DD097-5911-417A-8571-E8061F5011E5Q37718221-584699ED-7FC7-422B-856F-D911353953D1Q37720697-72D25AC5-B8E0-485E-B568-0CE61B1B2210Q37722129-36BEAF04-E9E2-4584-A946-8DCFFA832855Q38214535-233BB76A-B6C7-4A5E-8F15-752B3F75C958
P2860
Identification of driver genes in hepatocellular carcinoma by exome sequencing.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identification of driver genes in hepatocellular carcinoma by exome sequencing.
@en
Identification of driver genes in hepatocellular carcinoma by exome sequencing.
@nl
type
label
Identification of driver genes in hepatocellular carcinoma by exome sequencing.
@en
Identification of driver genes in hepatocellular carcinoma by exome sequencing.
@nl
altLabel
Identification of driver genes in hepatocellular carcinoma by exome sequencing
@en
prefLabel
Identification of driver genes in hepatocellular carcinoma by exome sequencing.
@en
Identification of driver genes in hepatocellular carcinoma by exome sequencing.
@nl
P2093
P2860
P356
P1433
P1476
Identification of driver genes in hepatocellular carcinoma by exome sequencing.
@en
P2093
Anand Ghanekar
Derek Y Chiang
Gleb L Savich
Joel S Parker
Maha Guindi
Michael C Wu
Michael S Lawrence
P2860
P304
P356
10.1002/HEP.26540
P407
P50
P577
2013-09-24T00:00:00Z